Bills › 89th General Assembly
Relating to insurance coverage for prescription insulin drugs, and including applicability provisions
Sponsored by the House Human Resources Committee
Topics:Health careInsurancePrescription drug prices
Same legislation: HSB 50
Where it is now
- Done: IntroducedJanuary 14, 2021
- Done: SubcommitteeJanuary 14, 2021
- Done: House committeeJanuary 27, 2021
- Done: Passes the HouseFebruary 8, 202189–2
- Stopped: Senate committeeDied when the General Assembly ended
- Next: Passes the Senate
- Next: To the Governor
- Next: Signed into law
Died when the session ended The 2022 session adjourned on May 24, 2022, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?
What’s in it
AI summary Health insurance plans in Iowa must limit how much a person pays out-of-pocket for certain types of insulin. For a 31-day supply of rapid, short, intermediate, or long-acting insulin, the total cost to the patient cannot be more than $100. This rule applies to specific insurance plans and contracts issued in the state.1
Read the official explanation
This bill relates to prescription insulin drugs and coverage by policies, contracts, or plans providing for third-party payment or prepayment of health or medical expenses that provide coverage for prescription drugs. The bill requires a policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses that provides coverage for prescription drugs to cap the total amount of cost-sharing that a covered person is required to pay per prescription filled to an amount not to exceed $100 for up to a 31-day supply of at least one type of each of rapid-acting prescription insulin drugs, short-acting prescription insulin drugs, intermediate-acting prescription insulin drugs, or long-acting prescription insulin drugs. “Prescription insulin drug” is defined in the bill as a prescription drug that contains insulin, is used to treat diabetes, has been prescribed as medically necessary by a covered person’s health care professional, and is a benefit covered by a covered person’s policy, contract, or plan. The bill defines “cost-sharing” as any coverage limit, copayment, coinsurance, deductible, or other out-of-pocket expense imposed on a covered person. The bill does not prohibit a policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses from reducing a covered person’s cost-sharing to less than $100 for a 31-day supply of a prescription insulin drug. The bill applies to third-party payment provider contracts, policies, or plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2022, by the third-party payment providers enumerated in the bill. The bill specifies the types of specialized health-related insurance which are not subject to the coverage requirements of the bill. The commissioner of insurance may adopt rules to administer the requirements of the bill.
Senate subcommittee
Named February 16, 2021. On March 17, 2021 it recommended passage.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Family tree
Tried before
Study bill
89th General Assembly
Earlier and later bills are matched by wording or an identical title.
Tried before
This idea has been filed in an earlier General Assembly. None became law, though one got through a chamber.
- HF 2138 Relating to insurance coverage for prescription insulin drugs88th General Assembly · Passed House · nearly identicalPassed a chamber
Similar bills this General Assembly
- HF 405 Relating to insurance coverage for prescription insulin drugs91st General Assembly · In committeeNearly identical
- HF 658 Relating to insurance coverage for prescription insulin drugs91st General Assembly · In committeeNearly identical
- SF 2047 Relating to insurance coverage for prescription insulin drugs91st General Assembly · In committeeNearly identical
- HF 502 Relating to insurance coverage for prescription insulin drugs90th General Assembly · In committeeNearly identical
- HF 694 Relating to insurance coverage for prescription insulin drugs90th General Assembly · In committeeNearly identical
- SF 2062 Relating to insurance coverage for prescription insulin drugs90th General Assembly · In committeeNearly identical
- SF 2322 Relating to insurance coverage for prescription insulin drugs91st General Assembly · In committeeVery similar
- SF 2214 Relating to insurance coverage for prescription insulin drugs90th General Assembly · Approved by committeeVery similar
- HF 2511 Relating to prescription refills in emergency situations and insurance coverage for prescr…89th General Assembly · In committeeVery similar
Matched by wording or an identical title.